Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis

• Main Authors: Huang Z (Author), Li H (Author), Zhang Q (Author), Tan X (Author), Lu F (Author), Liu H (Author), Li S (Author)
• Format: Book
• Published: Dove Medical Press, 2015-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Zhenhua Huang,1 Heran Li,1 Qian Zhang,2 Xiaojuan Tan,2 Fangzheng Lu,1 Hongzhuo Liu,1 Sanming Li11School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 2KBP BioSciences Co. Ltd., Jinan, Shandong, People’s Republic of ChinaAbstract: KBP-7018 is a novel selective tyrosine kinase i...